Recurrent Cytogenetic Abnormalities in Intravascular Large B-Cell Lymphoma. Issue 1 (14th May 2018)

• Record Type: Journal Article
• Authors: Klairmont, Matthew M; Cheng, Jinjun; Martin, Mike G; Gradowski, Joel F
• Is Part Of: American journal of clinical pathology. Volume 150:Issue 1(2018)
• Page Start: 18
• Page End: 26
• Publication Date: 2018-05-14
• Subjects: Intravascular large B-cell lymphoma -- Lymphoma -- Cytogenetics -- Karyotype -- Recurrent cytogenetic abnormalities; Diagnosis, Laboratory -- Periodicals; Pathology -- Periodicals; 616.07
• DOI: 10.1093/ajcp/aqy023
• Languages: English
• ISSNs: 0002-9173

Abstract

Abstract: Objectives: Data characterizing the cytogenetic landscape of intravascular large B-cell lymphoma (ILBCL) are limited. Here, we developed a comprehensive karyotypic data set to identify recurrent cytogenetic abnormalities in ILBCL. Methods: Cases of ILBCL with complete cytogenetic analysis were identified from an institutional database and the literature. The combined data were systematically reviewed for the presence of recurrent abnormalities. Results: Four new cases were identified and combined with 25 karyotypes previously published in the literature. Karyotypes were uniformly complex with a median of 10 aberrations. In total, 72.4% had abnormalities involving chromosome 1, with 31.0% involving rearrangements of 1p13 or 1q21; 58.6% had abnormalities involving chromosome 6, which in almost all cases involved 6q; 34.5% had abnormalities involving chromosome 14, with 27.6% involving rearrangements of 14q32; and 55.2% had abnormalities of chromosome 18, with 37.9% harboring trisomy 18. Conclusions: Recurrent cytogenetic abnormalities involving chromosomes 1, 6q, and 18 are present in greater than 50% of ILBCL.